Close

Geron Corp (GERN) Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology

Go back to Geron Corp (GERN) Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
Geron Corp (NASDAQ: GERN) Delayed: 3.32 +0.01 (0.30%)
Previous Close $3.31    52 Week High $5.30 
Open $3.32    52 Week Low $1.81 
Day High $3.34    P/E N/A 
Day Low $3.27    EPS $-0.35 
Volume 3,589,686